Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hiroki Takechi

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|June 9, 2019
N-Cadherin Orchestrates Self-Organization of Neurons within a Columnar Unit in the <i>Drosophila</i> MedullaOlena Trush, Chuyan Liu, Xujun Han, et al.
Cancer Medicine|June 14, 2022
Real-world data of atezolizumab plus carboplatin and etoposide in elderly patients with extensive-disease small-cell lung cancerAyako Shiono, Hisao Imai, Satoshi Wasamoto, et al.
Thoracic Cancer|September 5, 2022
Post-progression survival after atezolizumab plus carboplatin and etoposide as first-line chemotherapy in small cell lung cancer has a significant impact on overall survivalKen Masubuchi, Hisao Imai, Satoshi Wasamoto, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|June 9, 2019
N-Cadherin Orchestrates Self-Organization of Neurons within a Columnar Unit in the <i>Drosophila</i> MedullaOlena Trush, Chuyan Liu, Xujun Han, et al.
Cancer Medicine|June 14, 2022
Real-world data of atezolizumab plus carboplatin and etoposide in elderly patients with extensive-disease small-cell lung cancerAyako Shiono, Hisao Imai, Satoshi Wasamoto, et al.
Thoracic Cancer|September 5, 2022
Post-progression survival after atezolizumab plus carboplatin and etoposide as first-line chemotherapy in small cell lung cancer has a significant impact on overall survivalKen Masubuchi, Hisao Imai, Satoshi Wasamoto, et al.
Pageof 2